Southeast Asia Bioprocessing Market 2021

Southeast Asia Bioprocessing Market 2021

Deep-dive into Southeast Asia’s biopharma landscape with a comprehensive market & company analysis!
About Southeast Asia Bioprocessing Market 2021 Report

Access in-depth market and company analysis of over 30 biopharmaceutical companies in Southeast Asia working on various biologics products such as vaccines, monoclonal antibodies, ADCs, biosimilars and cell therapies.

Key Takeaways
  • Insights into the buying decisions of your potential clients, the key stakeholders and the effect of COVID-19 on their budget and therapeutic pipeline
  • Find your potential partners interested in your latest technologies or services offered
  • Evaluate your business model by doing a competitive study across various organisations listed
On-Demand Webcast

This live-moderated interview comes to you as part of the newly launched Southeast Asia Bioprocessing Market 2021 Intelligence Report. Catch the latest from the Southeast Asian Bioprocessing market in 2021. Representatives from PT Kalbe (Indonesia), CellVec (Singapore), and A*STAR (Singapore) share their insights on the following and much more!

– Market growth of biologics in the SEA region
– Challenges and limitations hindering the growth in SEA
– Impact on the SEA biologics market such as mAbs, recombinant protein, cell and gene therapy in the post-covid world
– Key SEA biologics players, emerging companies and their achievements

Sandy Qlintang, Director, PT Kalbe, Indonesia

Bi Xuezhi, Senior Scientist, Head of Proteomics, Analytical Science & Technologies, A*STAR, Singapore

Lucas Chan, Scientific founder & CSO, CellVec, Singapore

Report Snapshot

PURCHASE YOUR REPORT HERE!

For offline payments or inquiries, kindly contact Kashmiira Nayar at

e: kashmiira.nayar@imapac.com

t: +65 3109 0122

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users.

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

SECTION 1

  • Preface
  • Report scope & data coverage
  • IMAPAC’s research methodology

SECTION 2: MARKET OVERVIEW

  • Southeast Asia region
  • Country-wise – Thailand, Singapore, Malaysia, Indonesia, Vietnam
  • Driving factors and limitations for each market
  • Scope of growth for each market

SECTION 3: COMPANY OVERVIEW

  • Active pipelines
  • Partnerships and collaborations
  • Technology, equipment and solution providers
  • Future expansion plans

SECTION 4: COMPANY ANALYSIS

  • Customer profile, market trends and procurement process
  • Competition and market tactics
  • Companies’ KPI
  • Focus applications
  • Changes in regulations, per market
  • Deciding factors in choosing a vendor
  • Factors influencing their buying decisions
  • Effect of COVID-19 has on their budget for the next 3 years
  • Stakeholders and decision makers for procurement
  • Best supplier and the equipment used by their team
  • Therapeutic areas having new pipeline in their organization in the next 3 years?
  • Interview
  • References

SECTION 5: OUR OTHER REPORTS

  • Bibliography
  • Disclaimer
  • About us
  • Our other reports

Download the report preview for the full list of companies!

THAILAND

  • Siam Biosciences
  • Government Pharmaceutical Organisation
  • Tcels
  • Kingen Biotech
  • Bio-Net Asia
  • Queen Saovabha Memorial Institute

SINGAPORE

  • SingCell
  • BTI
  • Cell Research Corporation
  • Tessa Therapeutics
  • Dot Bio
  • Travecta Therapeutics
  • Prestige Biopharma
  • Esco Aster
  • Lion TCR

MALAYSIA

  • Malaysian Vaccine Pharmaceuticals
  • National Institutes of Biotechnology Malaysia

INDONESIA

  • Biofarma
  • PT Kalbe Global Biomedika
  • Daewoong Infion
  • Bandung Institute of Technology

VIETNAM

  • Nanogen Pharmaceutical Biotechnology
  • Vietnam Academy of Science and Technology
  • Vabiotech

and many more!